All Stories

  1. Reduced fibrinolytic resistance in patients with factor XI deficiency. Evidence of a thrombin-independent impairment of the thrombin-activatable fibrinolysis inhibitor pathway
  2. The paradoxical antifibrinolytic effect of dabigatran and argatroban in the presence of soluble thrombomodulin is unrelated to protein C-dependent increase of thrombin generation
  3. Influence of cell-associated tissue factor concentration on the anticoagulant activity of dabigatran. A possible explanation for the reduced incidence of intracranial bleeding
  4. Skin Extracts from 2 Italian Table Grapes (Italia and Palieri) Inhibit Tissue Factor Expression by Human Blood Mononuclear Cells
  5. Sepsis, thrombosis and organ dysfunction
  6. Thrombin activatable fibrinolysis inhibitor: At the nexus of fibrinolysis and inflammation
  7. SEPSIS-ASSOCIATED DISSEMINATED INTRAVASCULAR COAGULATION AND THROMBOEMBOLIC DISEASE
  8. The contribution of anti-Xa and anti-IIa activities to the profibrinolytic activity of low-molecular-weight heparins
  9. TAFI deficiency in liver cirrhosis: Relation with plasma fibrinolysis and survival
  10. Profibrinolytic activity of the direct thrombin inhibitor melagatran and unfractionated heparin in platelet-poor and platelet-rich clots
  11. Effect of ochratoxin A on prothrombotic and proinflammatory activities of stimulated blood mononuclear cells
  12. Hyperprothrombinaemia-induced APC resistance: Differential influence on fibrin formation and fibrinolysis
  13. THROMBOLYSIS ENHANCING ACTIVITY OF A LOW MOLECULAR WEIGHT DERMATAN SULFATE (DESMIN 370) IN EXPERIMENTAL PULMONARY EMBOLISM IN RATS
  14. Urinary procoagulant and fibrinolytic activity in human glomerulonephritis. Relationship with renal function
  15. Warfarin inhibits both procoagulant activity and metastatic capacity of Lewis Lung Carcinoma cells
  16. Leucocyte-dependent platelet activation: an alternative pathway for initiation of blood clotting in inflammation
  17. Role of leucocyte procoagulant activity in endotoxin-induced DIC: Evidence from comparative studies in rats and rabbits
  18. Reduced procoagulant activity of Lewis lung carcinoma cells from mice treated with warfarin